RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @MSeidmanMD: A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you…
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @onco_cardiology: Excellent job guys! Well done #JACCCaseReports @JGrapsa https://t.co/Pl5XXlceti
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @onco_cardiology: Excellent job guys! Well done #JACCCaseReports @JGrapsa https://t.co/Pl5XXlceti
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
RT @kdjhaveri: AmAzing article https://t.co/j4Evbo5FyT
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
Excellent job guys! Well done #JACCCaseReports @JGrapsa
RT @poojaotherwise: Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical…
Check out our new article on how to effectively utilize #SoMe to promote your case report and learn about rare clinical scenarios. Thank you @purviparwani @mmamas1973 @AChoiHeart @ChamsiPash @rafavidalperez @JGrapsa #JACCCaseReports for this opportunity!
RT @kdjhaveri: AmAzing article https://t.co/j4Evbo5FyT
AmAzing article https://t.co/j4Evbo5FyT
RT @MSeidmanMD: A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you…
RT @MSeidmanMD: A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you…
RT @MSeidmanMD: A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you…
RT @MSeidmanMD: A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you…
RT @MSeidmanMD: A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you…
A fantastic guide to the pros/cons of case reports by #PeerReview #PeerReviewWeek versus by #SocialMedia #SoMe - thank you @purviparwani @AChoiHeart @poojaotherwise @ChamsiPash @rafavidalperez @mmamas1973 https://t.co/0Bl2k35ahy
RT @DrDoblas: Social Media. The New Paradigm for Cardiovascular Case Reports https://t.co/OaX8bdgg67
Social Media. The New Paradigm for Cardiovascular Case Reports https://t.co/OaX8bdgg67